Andrei Stoica

Chief Tech/Sci/R&D Officer presso BUTTERFLY NETWORK, INC.

Patrimonio netto: 2 M $ in data 31/03/2024

51 anni

22 relazioni

Health Technology

Consumer Services

Health Services

Profilo

Andrei Stoica is currently the Chief Technology Officer at Butterfly Network, Inc. He previously worked as the Chief Technology Officer at BioTelemetry, Inc. and as the Vice President-Systems Development at IQVIA Holdings, Inc. He holds a doctorate degree from the University of South Carolina.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
BUTTERFLY NETWORK, INC. CLASS A 0.82%	02/04/2024	1 497 558 ( 0.82% )	2 M $	31/03/2024

Posizioni attive di Andrei Stoica

Società	Posizione	Inizio
BUTTERFLY NETWORK, INC.	Chief Tech/Sci/R&D Officer	19/07/2021

Tutte le posizioni attive di Andrei Stoica

Precedenti posizioni note di Andrei Stoica

Società	Posizione	Fine
BIOTELEMETRY, INC.	Chief Tech/Sci/R&D Officer	-
IQVIA HOLDINGS INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Andrei Stoica

Formazione di Andrei Stoica

University of South Carolina

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrei Stoica

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
IQVIA HOLDINGS INC.	Health Services
BUTTERFLY NETWORK, INC.	Health Technology

Aziende private	1
BioTelemetry, Inc. BioTelemetry, Inc. Medical SpecialtiesHealth Technology BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.	Health Technology

Aziende private